Thomas Wiglenda

Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils

Jan Bieschke, Martin Herbst, Thomas Wiglenda et al. · Nature Chemical Biology · 2011 · 442 citations

Life Sciences, Biochemistry, Molecular Biology +15

Antitumor-Active Cobalt−Alkyne Complexes Derived from Acetylsalicylic Acid:  Studies on the Mode of Drug Action

Ingo Ott, Kathrin Schmidt, Brigitte Kircher et al. · Journal of Medicinal Chemistry · 2004 · 205 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Structure−Activity Relationship Study To Understand the Estrogen Receptor-Dependent Gene Activation of Aryl- and Alkyl-Substituted 1<i>H</i>-Imidazoles

Thomas Wiglenda, Ronald Gust · Journal of Medicinal Chemistry · 2007 · 84 citations

Life Sciences, Molecular Biology, Pharmacology +17

Synthesis and Pharmacological Evaluation of 1<i>H</i>-Imidazoles as Ligands for the Estrogen Receptor and Cytotoxic Inhibitors of the Cyclooxygenase

Thomas Wiglenda, Ingo Ott, Brigitte Kircher et al. · Journal of Medicinal Chemistry · 2005 · 71 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Mixing Aβ(1–40) and Aβ(1–42) peptides generates unique amyloid fibrils

Linda Cerofolini, Enrico Ravera, Sara Bologna et al. · Chemical Communications · 2020 · 61 citations · Full text

Life Sciences, Biochemistry, Biophysics +17